-
October 13, 2021 Why Psychedelic Stocks Have Crashed in the Last 3 MonthsOur resident psychedelic investor explains why psychedelic stocks are plummeting, and why patience can pay...
-
October 13, 2021 FDA Backs Ketamine to Treat This Rare and Debilitating Pain SyndromeFood and Drug Administration grants psychedelic biotechnology company PharmaTher orphan drug designation for ketamine to...
-
October 13, 2021 Interview with Joseph Mays, IRI Program Director at ChacrunaIn our conversation with Joseph, we chat a bit about some critical topics such as...
